Search Results - "Falkson CI"

Phase II study of Ifosfamide+Doxorubicin in patients with advanced synovial sarcomas (E1793): a trial of the Eastern Cooperative Oncology Group.

Authors: Edmonson JH Ryan LM Falkson CI et al.

Source: Sarcoma. Mar2003, Vol. 7 Issue 1, p9-9. 1p.

URL: 9756171

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.

Authors: Hallemeier CL Moughan J Haddock MG et al.

Source: JAMA network open [JAMA Netw Open] 2023 Apr 03; Vol. 6 (4), pp. e238504. Date of Electronic Publication: 2023 Apr 03.

Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Erratum to: Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report.

Authors: Kharel Z Nemer OP Xi W et al.

Source: Breast disease [Breast Dis] 2022; Vol. 41 (1), pp. 363.

Publication Type: Published Erratum

Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 8801277 Publication Model: Print Cited Medium: Internet ISSN: 1558-1551 (Electronic) Linking ISSN: 08886008 NLM ISO Abbreviation: Breast Dis Subsets: MEDLINE; PubMed not MEDLINE

Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report.

Authors: Kharel Z Nemer OP Xi W et al.

Source: Breast disease [Breast Dis] 2022; Vol. 41 (1), pp. 255-260.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 8801277 Publication Model: Print Cited Medium: Internet ISSN: 1558-1551 (Electronic) Linking ISSN: 08886008 NLM ISO Abbreviation: Breast Dis Subsets: MEDLINE

Adjuvant tamoxifen adherence in male patients with breast cancer: An ongoing challenge.

Authors: Falkson CI; James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.

Source: Cancer [Cancer] 2022 Jan 01; Vol. 128 (1), pp. 22-24. Date of Electronic Publication: 2021 Oct 01.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.

Authors: Yee D Isaacs C Wolf DM et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2021 Oct 05; Vol. 7 (1), pp. 131. Date of Electronic Publication: 2021 Oct 05.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).

Authors: Kizub DA Miao J Schubert MM et al.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 May; Vol. 29 (5), pp. 2509-2517. Date of Electronic Publication: 2020 Sep 15.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Impact of early dose intensity reduction of Palbociclib on clinical outcomes in patients with hormone-receptor-positive metastatic breast cancer.

Authors: Moftakhar B Lekkala M Strawderman M et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Sep; Vol. 183 (2), pp. 411-418. Date of Electronic Publication: 2020 Jul 15.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.

Authors: Gralow JR Barlow WE Paterson AHG et al.

Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Jul 01; Vol. 112 (7), pp. 698-707.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104).

Authors: Goldstein LJ Zhao F Wang M et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Sep; Vol. 165 (2), pp. 375-382. Date of Electronic Publication: 2017 Jun 16.

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.

Authors: Stringer-Reasor EM May JE Olariu E et al.

Source: Breast cancer research : BCR [Breast Cancer Res] 2021 Mar 04; Vol. 23 (1), pp. 30. Date of Electronic Publication: 2021 Mar 04.

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Less Toxic Chemotherapy in Locally Advanced Breast Cancer.

Authors: Carpenter J Forero A Falkson CI et al.

Source: Southern medical journal [South Med J] 2020 Nov; Vol. 113 (11), pp. 559-563.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Southern Medical Association Country of Publication: United States NLM ID: 0404522 Publication Model: Print Cited Medium: Internet ISSN: 1541-8243 (Electronic) Linking ISSN: 00384348 NLM ISO Abbreviation: South Med J Subsets: MEDLINE

Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.

Authors: Forero-Torres A Saleh MN Galleshaw JA et al.

Source: Clinical breast cancer [Clin Breast Cancer] 2010 Aug 01; Vol. 10 (4), pp. 275-80.

Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma.

Authors: Falkson CI Falkson G

Source: Oncology [Oncology] 1999 Oct; Vol. 57 (3), pp. 232-5.

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin.

Authors: Falkson CI Cohen GL

Source: Oncology [Oncology] 1998 Mar-Apr; Vol. 55 (2), pp. 116-21.

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992.

Authors: Falkson CI Falkson HC

Source: Oncology [Oncology] 1998 Jan-Feb; Vol. 55 (1), pp. 59-64.

Publication Type: Journal Article

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

Authors: Lin NU Guo H Yap JT et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 Aug 20; Vol. 33 (24), pp. 2623-31. Date of Electronic Publication: 2015 Jul 13.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

Authors: Paterson AH Anderson SJ Lembersky BC et al.

Source: The Lancet. Oncology [Lancet Oncol] 2012 Jul; Vol. 13 (7), pp. 734-42. Date of Electronic Publication: 2012 Jun 14.

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.

Authors: Rossman JF Falkson CI Xu R et al.

Source: Gastrointestinal cancer research : GCR [Gastrointest Cancer Res] 2011 Jan; Vol. 4 (1), pp. 9-14.

Publication Type: Journal Article

Journal Info: Publisher: International Society of Gastrointestinal Oncology Country of Publication: United States NLM ID: 101300691 Publication Model: Print Cited Medium: Internet ISSN: 1934-7987 (Electronic) Linking ISSN: 19347820 NLM ISO Abbreviation: Gastrointest Cancer Res Subsets: PubMed not MEDLINE

Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92).

Authors: Wiernik PH Dutcher JP Yao X et al.

Source: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2010 Nov-Dec; Vol. 33 (9), pp. 1006-9.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE